cardamonin and indirubin-3--monoxime

cardamonin has been researched along with indirubin-3--monoxime* in 1 studies

Other Studies

1 other study(ies) available for cardamonin and indirubin-3--monoxime

ArticleYear
Cardamonin suppresses melanogenesis by inhibition of Wnt/beta-catenin signaling.
    Biochemical and biophysical research communications, 2009, Dec-18, Volume: 390, Issue:3

    Wnt/beta-catenin signaling plays important roles in many developmental processes, including neural crest-derived melanocyte development. Here we show that cardamonin, a calchone from Aplinia katsumadai Hayata, inhibited pigmentation in melanocytes through suppression of Wnt/beta-catenin signaling pathway. Cardamonin significantly suppressed the expression of microphthalmia-associated transcription factor (MITF) and tyrosinase, which are melanocyte differentiation-associated markers, in human normal melanocytes, thereby decreasing intracellular melanin production. In addition, cardamonin promoted the degradation of intracellular beta-catenin that was accumulated by Wnt3a-conditioned medium (Wnt3a CM) or bromoindirubin-3'-oxime (BIO), a glycogen synthase kinase-3beta (GSK-3beta) inhibitor, in HEK293 reporter cells and human normal melanocytes. Our findings indicate that cardamonin may be a potential whitening agent for use in cosmetics and in the medical treatment of hyperpigmentation disorders.

    Topics: beta Catenin; Cell Line; Chalcones; Glycogen Synthase Kinase 3; Humans; Indoles; Melanins; Melanocytes; Oximes; Skin Pigmentation; Wnt Proteins

2009